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Abstract
Purpose: The aim of this in vitro study was to evaluate the effect of mouthwashes with and 
without alcohol on some microorganisms. 
Methods: Periogard®, Cepacol®, Plax Classic® and Oral-B® were the substances tested. For   
this study, 40 plates of Petri with medium blood agar were used for the following microorganisms: 
Staphylococcus aureus, Candida albicans, Enterococcus faecalis, Pseudomonas aeruginosa. 
To measure the inhibition zones, a single trained examiner used a stereomicroscope and a 
digital caliper. After data collection, the medias were compared using the ANOVA (analysis of 
variance) with Bonferroni test post-hoc correction for 5% significance level. 
Results: Periogard®, with and without alcohol, showed the best results. Plax® without alcohol 
presented the poorest results. Plax® with alcohol was the best substance in relation to S. aureus. 
The others results remained with better effectiveness in relation to control substance. 
Conclusion: The alcohol-free mouthwashes did not have the same efficacy of antimicrobial 
rinses with alcohol in relation to microorganisms tested in this study.
Key words: Mouthwash; chlorhexidine
Resumo
Objetivo: O objetivo desse estudo in vitro foi de avaliar a ação antimicrobiana de enxaguatórios 
bucais com e sem álcool. 
Metodologia: Usaram-se no estudo o Periogard®, o CEPACOL®, Plax Classic® e o ORAL-B®, 
anti-séptico sem álcool. Para a realização desse estudo foram utilizadas 40 placas de Petri com 
meio de cultura de Ágar Sangue para os seguintes microrganismos: Staphylococcus aureus, 
Candida albicans, Enterococcus faecalis, Pseudomonas aeruginosa. Para a mensuração dos 
halos de inibição, um único examinador treinado utilizou uma lupa estereoscópica e um 
paquímetro digital. Após a coleta dos dados, as médias foram comparadas utilizando-se do 
teste estatístico ANOVA (análise de variância) com teste corretivo de Bonferroni, para nível 
de significância de 5%. 
Resultados: O Periogard® com álcool e o sem álcool apresentaram os melhores resultados. 
O Plax® sem álcool obteve os piores resultados. O Plax® com álcool foi melhor substância 
em relação ao S. aureus. Os demais resultados mantiveram-se com melhor efetividade em 
relação à substância controle. 
Conclusão: Os enxaguatórios sem álcool não têm a mesma eficácia antimicrobiana comparada 
aos enxaguatórios com álcool em relação aos microrganismos testados neste estudo.
Palavras-chave: Antissépticos bucais; clorexidina
Original Article  Rev. odonto ciênc. 2010;25(2):178-181  179
Borges et al.
Introduction
Generally, patients on intensive care do not have adequate 
bucal higienization (1). This condition can cause periodontitis 
and gingivitis, ear infections, chronic rhinopharyngitis, 
xerostomy, possible outbreaks of nosocomial infections 
prone to pneumonia (2). The bacterial dental plaque, also 
designated as dental biofilm, produces irritant substances 
(acids, endotoxins and antigens) that potentially destroy 
teeth and support tissues (3). 
The  mouthwash  use  is  an  excellent  tool  in  the  dental 
biofilm control. Can be used as an auxiliary way for the 
dental biofilm mechanical removal by the dentist or in 
complementation to toothbrushing of the patient (4). Many 
times, the chemical resource used can be prolonged. Besides 
this fact, these substances have in their composition the 
presence of detergent, alcohol and dye, elements which can 
prejudice the bucal mucosis (5).
The  alcohol  is  considered  as  risk  factor  for  oral  and 
oropharynx cancer development. Its pathogenesis is not still 
properly clear, requiring care in the approach of these lesions 
origin (6,7). Extensive discussion has been conducted about 
the prolonged use of alcohol-free mouthwash. However, it 
is not clear if the alcohol added to mouthwash can give rise 
to problems (8).
Based on findings which report the relation of the alcohol 
present  in  bucal  mouthwashes  and  eventual  lesions  in 
oral cavity, alternative products with greater substantivity 
and  alcohol  free  are  researched.  In  this  context,  it  is 
important to evaluate the mouthwash antimicrobial ability, 
with and without alcohol, marketed in Brazil, against to 
Staphylococcus aureus, Candida albicans, Enterococcus 
faecalis and Pseudomonas aeruginosa
Methodology
Periogard® (Colgate-Palmolive, Indústria Brazileira, São 
Bernardo do Campo, SP, Brazil), Cepacol ® (Sanofi Aventis 
Farmacêutica  Ltda,  Suzano,  SP,  Brazil),  Plax  Classic® 
(Colgate-Palmolive, Indústria Brasileira, São Bernardo do 
Campo, SP, Brazil) and Oral-B® non-alcohol anti-septic 
(Procter & Gamble do Brazil, São Paulo, SP, Brazil) were 
selected for the tests, as described in Table 1. Distilled water 
was used as control substance. These products were acquired 
in specialized stores in Cuiabá-MT, Brazil.
For the completion of this study, had been used 40 Petri dishes 
(48x12 mm, without division) with agar-blood medium 
(Newprov, Produtos Médicos e Hospitalares, São José dos 
Pinhais, PR, Brazil) for the microorganisms: Staphylococcus 
aureus (ATCC 6538), Candida albicans (ATCC 10231), 
Enterococcus faecalis (ATCC 10231) and Pseudomonas 
aeruginosa (ATCC 27853). Four Petri dishes with the agar-
blood medium were selected for the microorganism growth 
evaluation, designated as positive control. In other 4 dishes, 
the sowing of the microorganism was not done, aiming to 
evaluate the medium contamination absence, designated as 
negative control.
The microorganisms were inoculated in 7 mL of BHI (Brain 
Heart Infusion- Difco Laboratories, Detroit, MI, United 
States) and taken to bacterial incubator (Fanem model 502 
– Industrias Fanem Ltda, São Paulo, SP, Brazil) at constant 
temperature of 37°C, for 24 hours, for replication. 
The aim was that, at the end of this phase, the microorganism 
concentration was close to 3x108 cels/ mL, similar to tube 
#1 in MacFarland scale. The microorganisms used in this 
study were tested only in aerobiosis conditions.
For  the  diffusion  test,  0.1  mL  of  the  suspension  was 
inoculated, with the aid of sterile swabs (Rayswab Indústria 
Brasileira, Diadema, SP, Brazil).
The next step was the insertion of the absorbent paper disks, 
with 5 mm-diameter, obtained by patterned perforation of 
coffee filter paper (Melitta do Brazil, Ind. e Com. Ltda, 
São Paulo, SP, Brazil). These disks were properly sterelized 
and moistened in each substance test, as known: Cepacol® 
(Hoechst Marion Roussel, Indústria Brasileira, São Paulo, 
SP, Brazil) Periogard® with and without alcohol (Colgate-
Palmolive, Indústria Brasileira, São Bernardo do Campo, SP, 
Brazil), Plax® with and without alcohol (Colgate-Palmolive, 
Indústria Brasileira, São Bernardo do Campo, SP, Brazil) 
Oral B® without alcohol (Procter & Gamble do Brazil, São 
Paulo, SP, Brazil ) and water, distilled and dionized, as 
control. All of disks were immersed in equal time (superior 
to 1 min) in respective substances and in sequence, deposited 
neatly on sterile gauze to remove liquid excess. At the end 
of this phase, the dishes were to incubator at 37°C for   
48 hours.
For  the  inhibition  hales  mensuration,  in  millimeters,  a 
single trained examiner used a stereoscopic magnifying and 
milimetric regua (Jon, Com. de Produtos Odontológicos, 
São Paulo, SP, Brazil). The medium values and standard 
Table 1. Description of the tested substances with respective composition and manufacturer identification.
Substance Composition* Manufacturer
CEPACOL® Cetilperidine chlorete (0.500 mg)  Sanofi Aventis Farmacêutica Ltda, Suzano, SP , Brazil
ORAL B® antiseptic  Timol Procter & Gamble do Brazil, São Paulo, SP , Brazil
PLAX® Triclosan Colgate-Palmolive, Ind. Bras., São Bernardo do Campo, SP , Brazil
PLAX® (non-alcohol) Triclosan Colgate-Palmolive, Ind. Bras., São Bernardo do Campo, SP , Brazil
PERIOGARD® 0.12% chlorhexidine gluconate Colgate-Palmolive, Ind. Bras. São Bernardo do Campo, SP , Brazil
PERIOGARD® (non-alcohol) 0.12% chlorhexidine gluconate Colgate-Palmolive, Ind. Bras. São Bernardo do Campo, SP , Brazil
* according to the manufacturers.180  Rev. odonto ciênc. 2010;25(2):178-181
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deviation  were  determined  for  all  substances  and,  in 
sequence, compared each other. ANOVA statistical test was 
conducted with Bonferoni corrective test, at 5% significance 
level.
Results
Table 2 shows the means and standard deviation of inhibition 
hales,  in  millimeters,  formed  by  the  tested  substances. 
In comparisons related to microorganism as S.  aureus, 
C. albicans, E. faecalis and P. aeruginosa, cetilpiridine 
chloride with (Cepacol®) and without alcohol (Oral-B®) did 
not presented significant statistically differences (p>0,05), 
related to inhibition hales mensuration. 
In the Plax® substances analysis, the product with alcohol 
demonstrated inhibition hale with minor diameter (p<0.05) 
for S. aureus, C. albicans and E. faecalis. Referring to P. 
Aeruginosa, Plax® without alcohol did not demonstrated 
statistically  difference  in  relation  to  control  substance 
(p>0.05), considering the size of the inhibition hale.
For Periogard®, the substance without alcohol presented 
the greatest inhibition hales (P<0.05) for S. aureus. In 
comparision with C. albicans, E. faecalis and P. aeroginosa, 
there were no statistically significant differences (P>0.05) 
between these two tested substances. For Periogard®, with 
and without alcohol, can be observed that only S.aureus had 
result with better antimicrobial action and with statistically 
significance (P<0.05) for the substance with alcohol. In 
comparison to others microorganisms, S. aureus, C. albicans, 
E. faecalis and P. aureginosa did not presented statistically 
differences (P>0.05) between these two tested substances. 
For the microorganism E. faecalis, Cepacol®, with and 
without  alcohol,  Periogard®,  with  and  without  alcohol 
and Plax® with alcohol did not demonstrated statistically 
differences (P>0.05) between the groups. Plax® with alcohol 
showed antimicrobial effectiveness similar to the control 
substance (P>0.05). 
In relation to C. albicans, Plax® with alcohol presented the 
greatest values of antimicrobial effectiveness (P<0.05). 
The others substances evidenced medium antimicrobial 
effectiveness,  however,  better  results  than  the  control 
substance (P<0.05). For this microorganism, Plax® without 
alcohol presented the minor values of antimicrobial activity 
(P<0.05), similar to control substance (P>0.05). 
In relation to microorganism P. aeruginosa, Periogard®, with 
and without alcohol, demonstrated the greater antimicrobial 
activity compared to others substances (P<0.05). 
Discussion
Until to the moment, it is not consensus the role of the 
alcohol, present in bucal mouthwashes, can predispose to 
neoplasic lesions appearance in oral cavity and oropharynx 
(6,7). The literature provides conflicting results. Blank et 
al. (8) report that does not exist evidences correlating these 
lesions to mouthwashes with alcohol. This statement was 
reinforced by experiments in which rats were subjected for 
20 weeks to mouthwashes with alcohol in their composition, 
and after the test period, the animals showed no indications of 
carcinogenesis (9). By other side, in case-control study was 
observed a greater risk of patients who used mouthwashes 
with alcohol in developing neoplasic diseases in oral cavity 
and pharynx (10). 
At same time that bucal antiseptics are been considered 
indispensable tools in infection control (11), another point 
to be discussed is the fact that this infection focus can be 
collaborator in the systemic diseases development (12,13). 
The dentist is considered an important member in the health 
promotion team (12). Patients, in critic health conditions, 
moreover in Intensive Care Unity (ICU), present a deficient 
oral hygiene with great amount of dental biofilm (13). Some 
cases of ICU stay are long term, increasing the virulence over 
the time (2,14). For the control of microorganisms linked to 
systemic nosocomial complication and opportunist diseases, 
bucal antiseptics alcohol-free are been used (6-8), raising 
the necessity to investigate the effectiveness of alcohol-free 
products for this purpose.
In  this  study,  chlorhexidine,  with  and  without  alcohol, 
evidenced the best results, in agreement to others in vitro 
investigations (15,16). This substance, in dentistry research, 
is considered as gold-pattern in comparisons to others bucal 
antiseptics (4,17), although is so relevant that others studies 
should confirm the antimicrobial action of this product, with 
alcohol in its composition. The chlorhexidine without alcohol 
seems to maintain the antimicrobial action, in vitro essay. 
Certainly, the substantivity, great antimicrobial spectrum 
and the action in organic medium shall remain, even without 
alcohol. Probably, chlorhexidine without alcohol will have 
Table 2. Means* and standard deviation of inhibition hales (in millimeters) formed by the tested substances.
Substances
Microorganisms
S. aureus C. albicans E. faecalis P . aureginosa
CEPACOL® 9.25±1.00 a,f 7.75±0.65 ad 8.00±1.30 a 5.00±0.00 a
ORAL B (non-alcohol) 8.87±1.72 a 8.50±0.75 d 8.31±0.65 a 5.00±0.00 a
PLAX® 15.68±0.79 d 6.56±0.56 c,a 7.31±0.68 a 5.00±0.00 a
PLAX® (non-alcohol) 5.00±0.0 g 5.00±0.00 e 5.43±0.82 b 5.00±0.00 a
PERIOGARD® 13.10±2.09 c 10.37±1.18 b 9.00±1.00 a 7.50±0.46 b
PERIOGARD® (non-alcohol) 10.56±0.41 f 9.75±1.16 f,b 8.87±1.27 a 7.18±0.45 d,b
Distilled and dionized water 5.00±0.00 g 5.00±0.00 e 5.00±0.00 b 5.00±0.00 a
* Different letters in columns mean statistically difference (P<0.05, ANOVA with Bonferroni pos-hoc test).   Rev. odonto ciênc. 2010;25(2):178-181  181
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importance as bucal antiseptic as the ones with alcohol   
have (18-22). One of the interesting point in the study is 
related to the fact that Plax® without alcohol demonstrated 
absence of antimicrobial efficiency compared to the control 
substance. By other side, Plax® with alcohol showed the best 
results in relation to S. aureus, evidences in agreement to 
others studies (15,16).
In vitro studies with methodology of culture in Petri dishes 
are  still  used  to  perform  antibiograms  and  to  discover   
new microorganisms (23,24). These techniques, in many 
places, are not replaced by more advanced diagnostic in 
microbiology  (24). The  results  in  this  study  should  be 
carefully interpreted because they cannot deal the dental 
biofilm complexity, a limitation in any current technique, 
and why they do not deal any issue about the quality control 
of the products. However, it seems that there is the need for 
further clarification with other in vitro studies and also in 
health practice. 
Because  the  microorganisms  used  in  this  study  are 
colonizers of the oral and oro-pharynix cavity, often related 
to nosocomial infections (11,13), it is imperative the use 
of others bucal antiseptics as alternative. Even the results 
demonstrated relevant differences in the antimicrobial effect 
of the bucal antiseptics, with and without alcohol, perceive 
the need of other in vitro and in vivo investigations to confirm 
the results presented in this study.
Conclusion
The  alcohol-free  mouthwashes  did  not  present  anti- 
microbial action similar to alcohol ones, in relation to tested 
microorganisms in this study.
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